Literature DB >> 23538239

Familiarity and self-reported compliance with American Urological Association best practice recommendations for use of thromboembolic prophylaxis among American Urological Association members.

Steve Sterious1, Jay Simhan, Robert G Uzzo, Boris Gershman, Tianyu Li, Karthik Devarajan, Daniel Canter, John Walton, Ryan Fogg, Serge Ginzburg, Anthony Corcoran, Marc C Smaldone, Alexander Kutikov.   

Abstract

PURPOSE: Thromboprophylaxis with subcutaneous heparin or low molecular weight heparin is now an integral part of national surgical quality and safety assessment efforts, and has been incorporated into the current AUA Best Practice Statement. We evaluated familiarity and compliance with the AUA Best Practice Statement, assessed practice patterns in terms of perioperative thromboprophylaxis and specifically examined self-reported compliance in high risk patients undergoing radical cystectomy.
MATERIALS AND METHODS: An electronic survey was sent to AUA members with valid e-mail addresses (10,966). Associations between AUA Best Practice Statement adherence and factors such as urological specialty, graduation year and guideline familiarity were assessed using chi-square analyses and generalized estimating equations.
RESULTS: With 1,210 survey responses the largest group of respondents was urological oncologists and/or laparoscopic/robotic specialists (26.0%). This group was more likely to use thromboprophylaxis than nonurological oncologists and/or laparoscopic/robotic specialists in high risk patients (OR 1.3, CI 1.1-1.5). Respondents aware of the AUA Best Practice Statement guidelines (50.7%) were more likely to use thromboprophylaxis (OR 1.4, CI 1.2-1.6). Although 18.1% of urological oncologists and/or laparoscopic/robotic specialists and 34.2% of nonurological oncologists and/or laparoscopic/robotic specialists avoided routine thromboprophylaxis in patients undergoing radical cystectomy, the former were more likely to use thromboprophylaxis (p <0.0001) than other respondents. Urologists graduating after the year 2000 used thromboprophylaxis in high risk patients undergoing radical cystectomy more often than did earlier graduates (79.2% vs 63.4%, p <0.0001).
CONCLUSIONS: Although younger age and self-reported urological oncologist and/or laparoscopic/robotic specialist status correlated strongly with thromboprophylaxis use, self-reported adherence to AUA Best Practice Statement was low, even in high risk cases with clear AUA Best Practice Statement recommendations such as radical cystectomy. These data identify opportunities for quality improvement in patients undergoing major urological surgery.
Copyright © 2013 American Urological Association Education and Research, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  AUA; American Urological Association; BPS; Best Practice Statement; DVT; LMWH; PTE; RC; SQH; TP; UOLRS; VTE; deep vein thrombosis; heparin; low molecular weight heparin; practice guidelines as topic; prevention and control; pulmonary thromboembolism; radical cystectomy; societies, medical; subcutaneous heparin; thromboembolism; thromboprophylaxis; urological oncologists and/or laparoscopic/robotic specialists; venous thromboembolism

Mesh:

Substances:

Year:  2013        PMID: 23538239     DOI: 10.1016/j.juro.2013.03.076

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  11 in total

Review 1.  Current Status of Robot-Assisted Radical Cystectomy and Intracorporeal Urinary Diversion.

Authors:  Raj Kurpad; Michael Woods; Raj Pruthi
Journal:  Curr Urol Rep       Date:  2016-06       Impact factor: 3.092

2.  Venous Thromboembolism Risk in Patients With Locoregional Urothelial Tract Tumors.

Authors:  Jorge D Ramos; Jonathan T Wingate; Roman Gulati; Elizabeth R Plimack; Lauren C Harshman; Thomas Powles; Simon J Crabb; Guenter Niegisch; Joaquim Bellmunt; Sylvain Ladoire; Ugo De Giorgi; Syed Hussain; Ajjai S Alva; Jack Baniel; Neeraj Agarwal; Jonathan E Rosenberg; Ulka N Vaishampayan; Matthew D Galsky; Evan Y Yu
Journal:  Clin Genitourin Cancer       Date:  2017-08-24       Impact factor: 2.872

3.  Is extended pharmacologic venous thromboembolism prophylaxis uniformly safe after radical cystectomy?

Authors:  Reza Mehrazin; Zachary Piotrowski; Brian Egleston; Daniel Parker; Jeffrey J Tomaszweski; Marc C Smaldone; Philip H Abbosh; Timothy Ito; Paul Bloch; Kevan Iffrig; Marijo Bilusic; David Y T Chen; Rosalia Viterbo; Richard E Greenberg; Robert G Uzzo; Alexander Kutikov
Journal:  Urology       Date:  2014-10-24       Impact factor: 2.649

Review 4.  Performance Measurement and Quality Improvement Initiatives for Bladder Cancer Care.

Authors:  Benjamin T Ristau; Marc C Smaldone
Journal:  Curr Urol Rep       Date:  2018-10-24       Impact factor: 3.092

5.  Current Practice Patterns Among Members of the American Urological Association for Male Genitourinary Lichen Sclerosus.

Authors:  E Charles Osterberg; Thomas W Gaither; Mohannad A Awad; Amjad Alwaal; Bradley A Erickson; Jack W McAninch; Benjamin N Breyer
Journal:  Urology       Date:  2016-03-03       Impact factor: 2.649

Review 6.  Thromboembolism in Patients with Bladder Cancer: Incidence, Risk Factors and Prevention.

Authors:  Piotr Zareba; Wilhelmina C M Duivenvoorden; Jehonathan H Pinthus
Journal:  Bladder Cancer       Date:  2018-04-26

7.  Use of venous-thrombotic-embolic prophylaxis in patients undergoing surgery for renal tumors: a questionnaire survey in the Nordic countries (The NORENCA-2 study).

Authors:  Lars Lund; Harry Nisen; Petrus Järvinen; Magnus Fovaeus; Eirikur Gudmundsson; Bjarne Kromann-Andersen; Börje Ljungberg; Frode Nilsen; Pernilla Sundqvist; Peter E Clark; Christian Beisland
Journal:  Res Rep Urol       Date:  2018-10-25

8.  Venous Thromboembolism and Peri-Operative Chemotherapy for Muscle-Invasive Bladder Cancer: A Population-based Study.

Authors:  Kelly Brennan; Safiya Karim; R Christopher Doiron; D Robert Siemens; Christopher M Booth
Journal:  Bladder Cancer       Date:  2018-10-29

9.  Highest risk of symptomatic venous thromboembolic events after radical cystectomy occurs in patients with obesity or nonurothelial cancers.

Authors:  Aaron M Potretzke; Kelvin S Wong; Fangfang Shi; William Christensen; Tracy M Downs; E Jason Abel
Journal:  Urol Ann       Date:  2015 Jul-Sep

10.  Ongoing efforts to reduce perioperative morbidity of radical cystectomy: towards widespread adoption of extended-duration thromboprophylaxis.

Authors:  Vignesh T Packiam; Joseph J Pariser
Journal:  Transl Androl Urol       Date:  2018-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.